Text
Manipulation of the gut microbiome could be a promising approach for novel preventive and therapeutic strategies against allergy. A new italian study published in Nature Communications claims.
Bacthera in collaboration with Seres Therapeutics announced to manufacture SER-109, an investigational oral microbiome therapeutic to treat recurrent Clostridioides difficile infection (CDI).
The mouth microbiota may be used as a potential biomarker and target for the diagnosis and treatment of colorectal cancer. A new study pulished in Cell Reports claims.
Bifidobacteria associated with breastmilk produce small molecules that may improve immune function. A new study published in Nature Microbiology claims the beneficial effects of breastfeeding.
The Microbiome Connect: Gut Therapeutics Summit returns face to face on the 7-8 December. Join the list today whilst tickets are still available and don't forget to use MP10 to…
Strategies to mitigate some of the collateral damages of antibiotic therapies are necessary. A new study published in Nature claims.
The grain quinoa contains polysaccharides that can induce the growth and activity of beneficial gut microbes. A new study published in Food Science & Nutrition claims
Gut microbes seem to regulate the number and function of immune cells of central nervous system. A new study published in The EMBO Journal claims.
Aging produces changes in the microbiota of the small intestine. These changes are distinct from those caused by drugs or concomitant conditions and they could influence human health.
20 years ago the world leading groups of experts FAO/WTO defined probiotics microorganisms in food and food supplements
